STUDY OF ANTICOAGULANT MECHANISM OF LOW-MOLECULAR-WEIGHT HEPARIN

被引:3
作者
HAMANO, S [1 ]
NISHIYAMA, M [1 ]
KOMATSU, H [1 ]
MIYATA, H [1 ]
IKEDA, S [1 ]
SAKURAGAWA, N [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV,DEPT CLIN LAB MED,SUGITANI,TOYAMA 93001,JAPAN
关键词
LMW-HEPARIN; FR-860-SEPHAROSE; UF-HEPARIN-SEPHAROSE; F.XA; THROMBIN; ATIII;
D O I
10.1016/0049-3848(92)90118-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The binding ability of low molecular weight heparin (FR-860), and conventional unfractionated heparin (UF-heparin) to factor Xa (F.Xa), thrombin and AT III was investigated using FR-860- and UF-heparin-Sepharoses. FR-860 could not bind directly to F.Xa. FR-860 bound to thrombin and AT III with stronger affinity to AT III than to thrombin. On the other hand, UF-heparin bound to F.Xa, thrombin and AT III with the strongest affinity to AT III followed by thrombin and F.Xa. AT III mediated the binding between F.Xa and FR-860 and accelerated the reaction between F.Xa and UF-heparin. On the other hand, AT III did not affect the binding between thrombin and FR-860 or UF-heparin. Diisopropyl fluorophosphate-treated thrombin inhibited the binding between AT III and FR-860, but not that between AT III and UF-heparin. These results suggest that the anti-F.Xa activity of FR-860 is mediated by AT III. Furthermore, the difference of antithrombin activity between FR-860 and UF-heparin depends on the capability to form ternary complex of FR-860 or UF-heparin, AT III and thrombin.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 17 条
[1]  
CARTER CJ, 1982, BLOOD, V59, P1239
[2]  
DANIELSSON A, 1986, J BIOL CHEM, V261, P5467
[3]   HEPARIN-CATALYZED INHIBITOR PROTEASE REACTIONS - KINETIC EVIDENCE FOR A COMMON MECHANISM OF ACTION OF HEPARIN [J].
GRIFFITH, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5460-5464
[4]   BENEFICIAL EFFECT OF LOW-MOLECULAR WEIGHT HEPARIN ON THE HEMODIALYSIS MODEL IN DOGS [J].
HAMANO, S ;
KOMATSU, H ;
IKEDA, S ;
TAKAHASHI, K ;
OGUMA, Y ;
SAKURAGAWA, N .
THROMBOSIS RESEARCH, 1989, 55 (04) :439-449
[5]   EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN (FR-860) ON THE EXPERIMENTAL DISSEMINATED INTRAVASCULAR COAGULATION MODELS [J].
HAMANO, S ;
KINUKAWA, M ;
KOMATSU, H ;
MIYATA, H ;
SAKURAGAWA, N .
FOLIA PHARMACOLOGICA JAPONICA, 1991, 98 (01) :53-62
[6]   EFFECTS OF LOW-MOLECULAR WEIGHT HEPARIN (FR-860) ON COAGULATIVE AND FIBRINOLYTIC-ACTIVITIES [J].
HAMANO, S ;
KINUKAWA, M ;
KOMATSU, H ;
IKEDA, S ;
SAKURAGAWA, N .
FOLIA PHARMACOLOGICA JAPONICA, 1989, 94 (04) :243-249
[7]   ANTITHROMBOTIC EFFECTS OF LOW-MOLECULAR WEIGHT HEPARIN (FR-860) IN RABBITS [J].
HAMANO, S ;
KOMATSU, H ;
IKEDA, S ;
SAKURAGAWA, N .
FOLIA PHARMACOLOGICA JAPONICA, 1989, 94 (04) :237-242
[8]   A METHOD FOR SYSTEMATIC PURIFICATION FROM BOVINE PLASMA OF 6 VITAMIN-K-DEPENDENT COAGULATION-FACTORS - PROTHROMBIN, FACTOR-X, FACTOR-IX, PROTEIN-S, PROTEIN-C, AND PROTEIN-Z [J].
HASHIMOTO, N ;
MORITA, T ;
IWANAGA, S .
JOURNAL OF BIOCHEMISTRY, 1985, 97 (05) :1347-1355
[9]  
HOLMER E, 1986, HAEMOSTASIS, V16, P1
[10]   ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW-MOLECULAR WEIGHT HEPARIN FRAGMENTS IN RABBITS [J].
HOLMER, E ;
MATTSSON, C ;
NILSSON, S .
THROMBOSIS RESEARCH, 1982, 25 (06) :475-485